Aspira Women's Health Inc.

AWHL

Aspira Women's Health Inc.

AWHL

Insider Sentiment (TTM):

Last Purchase:2026-06-05Last Sale:2023-12-06Shares Purchased (TTM):1,477,223Shares Sold (TTM):0

Institutional Sentiment:

As of:2025-12-31Institutional Shares Owned:33Shares Outstanding:34,102,760Institutional Ownership Pct.:0.00%

Earnings Market Reaction:

Filing Date:2026-05-15Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in In Vitro & In Vivo Diagnostic Substances

IDXX LNTH CLDX NTLA NEOG QDEL

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	1	2	4	2	3	2	2	1	3	3	5	4
Accounts Receivable Net Current	1	1	1	1	1	1	1	1	2	1	2	2
Prepaid Expense And Other Assets Current	1	1	0	1	1	1	0	1	1	1	1	1
Inventory Net	0	0	0	0	0	0	0	0	0	0	0	0
Assets Current	4	4	6	4	5	4	4	3	6	5	8	7
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Finite Lived Intangible Assets Net	0	0	0	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Asset	1	1	1	1	1	1	1	1	1	1	1	0
Restricted Cash Noncurrent	-	-	-	-	-	-	-	-	0	0	0	0
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	-
Assets	5	5	7	5	7	5	5	5	7	6	9	8
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	2	1	2	2	1	2	3	2	2	1	1	1
Accrued Liabilities Current	1	1	2	2	2	2	2	3	3	3	3	4
Long Term Debt Current	0	0	0	0	0	0	0	0	0	0	0	0
Short Term Borrowings	2	0	-	0	0	1	-	0	0	1	0	0
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	6	3	4	4	4	5	5	5	5	5	5	5
Liabilities Noncurrent
Long Term Debt Noncurrent	1	1	1	1	1	1	1	1	1	1	1	1
Operating Lease Liability Noncurrent	1	1	1	1	1	1	0	0	0	0	0	0
Warrants And Rights Outstanding	-	-	-	-	-	0	0	1	1	2	3	1
Liabilities	11	12	12	8	7	8	7	8	9	9	9	8
Stockholders Equity Inclu…
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity Note
Additional Paid In Capital Common Stock	537	537	536	533	533	529	527	523	522	516	515	507
Accumulated Other Comprehensive Income Loss Net Of…	-	-	-	-536	-533	-531	-530	-	-	-518	-	-
Retained Earnings Accumulated Deficit	-544	-544	-541	-	-	-531	-	-526	-523	-518	-515	-507
Stockholders Equity	-6	-7	-4	-3	-0	-3	-3	-4	-1	-2	-1	-1
Liabilities And Stockholders Equity	5	5	7	5	7	5	5	4	7	6	9	8
Allowance For Doubtful Accounts Receivable	0	0	0	0	0	0	0	0	0	0	35	0
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	-	-	0.001	-	-	-	-	-	-
Preferred Stock Shares Authorized	5	5	5	-	-	5	-	-	-	-	-	-
Preferred Stock Shares Issued	0	0	0	-	-	0	-	-	-	-	-	-
Preferred Stock Shares Outstanding	0	0	0	-	-	0	-	-	-	-	-	-
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	44	43	43	36	35	17	16	13	12	11	10	8
Shares Outstanding	44	43	43	36	35	17	16	13	12	11	10	8

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	7.69%	7.69%	-10.90%	-	-	-	-	-	-	-	-	-
2025	75.00%	137.50%	150.00%	200.00%	130.43%	121.74%	-21.57%	23.53%	-5.88%	14.29%	17.14%	40.00%
2024	-24.46%	-60.07%	-57.55%	-11.93%	-24.77%	-17.43%	5.63%	-11.27%	-50.70%	-72.73%	-27.27%	27.27%
2023	-	-	-	16.34%	56.90%	32.68%	-2.42%	19.09%	41.67%	11.37%	-23.41%	-44.82%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	0.68	1.17	1.39	0.90	1.42	0.76	0.75	0.60	1.16	1.03	1.47	1.28
Quick Ratio	0.49	0.85	1.22	0.69	1.16	0.50	0.62	0.44	0.93	0.79	1.30	1.09
Working Capital	-1.81M	598.00K	1.63M	-412.00K	1.60M	-1.29M	-1.35M	-2.21M	829.00K	161.00K	2.41M	1.49M
Leverage & Debt
Debt to Equity	-1.82	-1.79	-2.68	-2.84	-112.93	-3.14	-2.89	-2.07	-6.26	-3.65	-14.14	-15.62
Interest Coverage TTM	-26.65	-193.00	-189.81	-271.67	-352.57	-493.27	-771.91	-598.41	-640.07	-392.75	-271.34	-307.24
Debt Ratio	2.22	2.27	1.60	1.54	1.01	1.47	1.53	1.40	1.19	1.38	1.08	1.07
Efficiency & Turnover
Asset Turnover TTM	1.51	1.68	1.55	1.78	1.34	1.56	1.34	1.35	0.96	0.77	0.56	0.57
Days Sales Outstanding TTM	51.73	43.51	50.25	53.50	51.59	48.68	57.91	63.06	62.62	53.91	55.50	55.57
Receivables Turnover TTM	7.06	8.39	7.26	6.82	7.08	7.50	6.30	5.79	5.83	6.77	6.58	6.57
Per Share Metrics
Diluted EPS TTM	-0.22	-0.37	-0.30	-0.27	-0.48	-0.93	-0.96	-1.27	-1.24	-1.81	-1.86	-2.53
Free Cash Flow Per Share TTM	-0.10	-0.21	-0.17	-0.25	-0.50	-0.86	-0.95	-1.20	-1.24	-1.72	-2.01	-2.84
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	60.94%	64.18%	63.90%	63.93%	62.58%	59.67%	58.12%	57.84%	58.84%	57.48%	57.57%	56.82%
Operating Profit Margin TTM	-77.22%	-85.86%	-107.74%	-131.61%	-159.09%	-177.28%	-189.47%	-194.49%	-192.21%	-205.94%	-215.84%	-268.73%
Net Profit Margin TTM	-115.13%	-138.67%	-115.66%	-101.78%	-110.85%	-142.61%	-165.07%	-178.80%	-163.95%	-182.32%	-198.23%	-235.48%
Growth Metrics
Net Revenue Growth (1Y)	-4.34%	0.37%	4.17%	4.10%	3.53%	0.31%	-2.33%	-1.21%	4.46%	11.85%	16.43%	20.81%
Net Income Growth (1Y)	-0.65%	-2.40%	-27.01%	-40.74%	-30.00%	-21.55%	-18.67%	-24.99%	-45.80%	-44.15%	-46.89%	-41.21%
EPS Growth (1Y)	-50.68%	-59.55%	-69.10%	-79.14%	-61.60%	-48.75%	-48.39%	-49.67%	-61.96%	-53.01%	-57.59%	-47.63%
Valuation Metrics
P/E TTM	-1.53	-1.68	-1.65	-0.56	-0.19	-0.77	-0.84	-1.17	-2.49	-2.26	-2.88	-1.31
P/B TTM	-2.52	-3.10	-4.10	-1.99	-32.39	-3.92	-4.95	-5.03	-26.94	-15.93	-79.52	-52.66
P/S TTM	1.76	2.33	1.91	0.57	0.21	1.09	1.39	2.09	4.08	4.12	5.71	3.08
Market Cap	15.66M	21.48M	17.83M	5.33M	1.94M	10.04M	12.48M	18.65M	36.72M	37.67M	52.40M	27.80M
Enterprise Value	17.40M	21.50M	15.36M	5.34M	465.15K	10.39M	11.91M	19.44M	35.06M	37.34M	48.97M	25.20M
Calculated Values
Free Cash Flow TTM	-4.30M	-7.05M	-6.08M	-8.78M	-10.80M	-12.15M	-14.59M	-14.99M	-14.66M	-15.92M	-19.61M	-23.85M
Net Debt	1.75M	15.00K	-2.48M	1.00K	-1.48M	352.00K	-570.00K	784.00K	-1.66M	-331.00K	-3.43M	-2.60M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-05Purchase

Owner: Schuler, Jack W

Title: -

Shares: 222,222

Price/Share: $0.45

Value: $99,999.90

Shares Owned: 4,046,051

Relationship: TenPercentOwner

Ownership: Indirect

2025-09-17Purchase

Owner: Cohen, Jeffrey K

Title: -

Shares: 55,556

Price/Share: $0.45

Value: $25,000.20

Shares Owned: 374,906

Relationship: Director

Ownership: Direct

2025-09-17Purchase

Owner: Fraser, John D

Title: -

Shares: 16,389

Price/Share: $0.45

Value: $7,375.05

Shares Owned: 566,393

Relationship: Director

Ownership: Direct

2025-09-17Purchase

Owner: Cohen, Jeffrey K

Title: -

Shares: 55,556

Price/Share: $0.45

Value: $25,000.20

Shares Owned: 375,697

Relationship: Director

Ownership: Indirect

2025-09-17Purchase

Owner: Fraser, John D

Title: -

Shares: 16,389

Price/Share: $0.45

Value: $7,375.05

Shares Owned: 566,393

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-05	Schuler, Jack W	TenPercentOwner	-	Indirect	Purchase	222,222	0.45	$99,999.90	4,046,051	4
2025-09-17	Cohen, Jeffrey K	Director	-	Direct	Purchase	55,556	0.45	$25,000.20	374,906	4/A
2025-09-17	Fraser, John D	Director	-	Direct	Purchase	16,389	0.45	$7,375.05	566,393	4/A
2025-09-17	Cohen, Jeffrey K	Director	-	Indirect	Purchase	55,556	0.45	$25,000.20	375,697	4
2025-09-17	Fraser, John D	Director	-	Direct	Purchase	16,389	0.45	$7,375.05	566,393	4
2025-09-17	Schuler, Jack W	TenPercentOwner	-	Indirect	Purchase	1,111,111	0.45	$499,999.95	3,823,829	4
2024-07-09	Schuler, Jack W	TenPercentOwner	-	Direct	Purchase	6,536	-	-	6,536	4
2024-05-31	Sandford, Nicole	Director,Officer	Chief Executive Officer	Direct	Purchase	9,493	2.42	$22,973.06	70,596	4
2024-01-26	Sandford, Nicole	Director,Officer	President & CEO	Direct	Purchase	2,400	-	-	61,103	4
2024-01-26	Schuler, Jack W	TenPercentOwner	-	Indirect	Purchase	28,500	-	-	1,912,156	4
2023-12-06	Merchant, Minh Hoang	Officer	Secretary & General Counsel	Indirect	Sale	980	3.37	$3,302.60	0	4
2023-12-06	Sandford, Nicole	Director,Officer	President & CEO	Direct	Purchase	5,000	3.36	$16,800.00	58,703	4
2023-09-08	Hombeck, Torsten	Officer	Chief Financial Officer	Direct	Purchase	2,246	4.30	$9,657.80	3,000	4
2023-07-24	Parnell, Winfred	Director	-	Direct	Purchase	6,281	3.98	$24,998.38	31,513	4
2023-07-24	Vos, Ellen O'Connor	Director	-	Direct	Purchase	3,769	3.98	$15,000.62	32,878	4
2023-07-24	Fralick, Celeste Rachelle	Director	-	Direct	Purchase	754	3.98	$3,000.92	12,032	4
2023-07-24	Cavanaugh, Stefanie L.	Director	-	Direct	Purchase	6,281	3.98	$24,998.38	34,904	4
2023-07-24	Merchant, Minh Hoang	Officer	General counsel and secretary	Direct	Purchase	754	3.98	$3,000.92	3,865	4
2023-07-24	Herchuk, Jannie Prestridg…	Director	-	Direct	Purchase	8,794	3.98	$35,000.12	23,833	4
2023-07-24	Jordan, Veronica Gh	Director	-	Direct	Purchase	3,769	3.98	$15,000.62	34,575	4
2023-07-24	Hombeck, Torsten	Officer	Chief Financial Officer	Direct	Purchase	754	3.98	$3,000.92	754	4
2023-07-24	Schuler, Jack W	TenPercentOwner	-	Indirect	Purchase	181,800	2.75	$499,950.00	1,883,656	4
2023-07-24	Sandford, Nicole	Director,Officer	President & CEO	Direct	Purchase	12,563	3.98	$50,000.74	134,665	4
2023-07-24	Phan, Ryan Thinh	Officer	CSO & COO	Direct	Purchase	628	3.98	$2,499.44	3,939	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-12-31

0.00%

Inst. Shares: 33

Shares Outstanding: 34,102,760

2025-09-30

0.00%

Inst. Shares: 800

Shares Outstanding: 36,388,370

2025-06-30

0.13%

Inst. Shares: 45,389

Shares Outstanding: 35,564,032

2025-03-31

2.76%

Inst. Shares: 595,759

Shares Outstanding: 21,590,573

2024-12-31

10.22%

Inst. Shares: 1,444,578

Shares Outstanding: 14,134,626

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-12-31	33	34,102,760	0.00%
2025-09-30	800	36,388,370	0.00%
2025-06-30	45,389	35,564,032	0.13%
2025-03-31	595,759	21,590,573	2.76%
2024-12-31	1,444,578	14,134,626	10.22%
2024-09-30	2,026,900	15,405,672	13.16%
2024-06-30	1,384,962	12,518,725	11.06%
2024-03-31	1,892,333	11,846,075	15.97%
2023-12-31	524,702	9,233,306	5.68%
2023-09-30	607,856	9,776,436	6.22%
2023-06-30	674,779	8,400,157	8.03%
2023-03-31	7,911,525	8,313,091	95.17%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Aspira Women's Health Inc. (AWHL) — SEC Financial Statements & Analysis

Aspira Women's Health Inc. (AWHL) is a in vitro & in vivo diagnostic substances company, incorporated in DE. Aspira Women's Health Inc. trades on OTC as: AWHL. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Aspira Women's Health Inc. reported a -4.34% year-over-year revenue growth, a Gross Profit Margin of 60.94% (TTM), a Debt-to-Equity ratio of -1.82x, a Price-to-Sales (P/S) ratio of 1.76x (TTM), a Price-to-Book (P/B) ratio of -2.52 (TTM), at a market cap of $15.66M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -4.34%
Gross Profit Margin TTM: 60.94%
Debt To Equity: -1.82x
P/S TTM: 1.76x
P/B TTM: -2.52
Market Cap: $15.66M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Aspira Women's Health Inc. in?

Aspira Women's Health Inc. (AWHL) operates in the In Vitro & In Vivo Diagnostic Substances industry.

What is AWHL's market cap?

Aspira Women's Health Inc. (AWHL) has a market capitalization of $15.66M as of 2026-03-31.

What exchange does AWHL trade on?

Aspira Women's Health Inc. (AWHL) trades on the OTC.

Where is Aspira Women's Health Inc. incorporated?

Aspira Women's Health Inc. is incorporated in DE.

Aspira Women's Health Inc. (AWHL) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.